N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide

Term ID

CHEBI:96502

Synonyms

Definition

References

LINCS:LSM-7881

Ontology

ChEBI ( EBI )

Relationships

is a type of: organonitrogen compound organooxygen compound

organonitrogen compound organooxygen compound Show first 5 Terms
has_functional_parent: alpha-amino acid

alpha-amino acid Show first 5 Terms

Phenotype

Phenotype resulting from N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide

Phenotype where environments contain N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide

Phenotype modified by environments containing N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(4-morpholinyl)acetamide

Human Disease Model